In malignant processes, OPN and its isoforms are involved in the modulation of tumor-associated inflammation, invasiveness, drug resistance, and poor prognosis; even in specific cancer types, OPN is considered a biomarker [61,62,63]. This evidence concerns the gene SPP1 and neoplasm.